Labcompliance On-line Audio Seminar
This seminar has been recorded and is available on CD and for
instant download. All reference material as listed below and more is
available on a special seminar website. The website is regularly
updated with most recent information. In case there are questions
related to the topic, they can be submitted through a web form and
will be answered by the speaker. For ordering info
click here.
On-line Audio Seminar 171
Verification of Compendial Methods
Understanding and Implementing the New USP
Chapter <1226>
Recorded

Compendial methods such as USP standards are validated by the organization that
has developed and published the method. The FDA requires users of such methods
to demonstrate the user's competence to successfully run the method. For
example, 21 CFR 211.194 (a) states: The suitability of all testing methods used
shall be verified under actual conditions of use. However, the FDA does not give
any further guidance on how to do and document this. The USP has developed a
chapter about the verification of compendial methods. It is well known that FDA
inspectors require USP standards or equivalent procedures to follow. Therefore
pharmaceutical companies are advised to learn about the new chapter and about
FDA's interpretation. When implemented right the standard also helps to reduce
overall costs for implementing USP methods. Therefore there is lots of interest
in learning about the new chapter.
Key Questions are:
- What are FDA and international requirements for compendial
methods?
- What and how much should be tested?
- Do all compendial routine methods require verification?
- Should we verify all performance characteristics?
- How much can we deviate from the compendial method without
the need for a full revalidation?
- What to do if I the compendial procedure can not be
verified?
- How frequently should compendial methods be re-verified?
- What if our equipment was not included in the USP method
validation experiments
How does the this audio seminar help:
Answers will be presented by Dr. Ludwig Huber in a new
interactive audio seminar. During the seminar, the speaker will
present the requirements for method verification and give practical
recommendations. After the seminar, an extensive list of reference
material like SOPs, worksheets, templates and examples will help
immediate and cost effective implementation.
During the interactive presentation you learn about:
- FDA and international requirements
- The background on scope of USP <1226>
- Status and timeline for implementation
- Compendial methods not requiring verification
- USP <1226> requirements
- The USP high level verification process
- Risk based approach for testing
- Criteria and examples for degree and extent of the
verification
- Performance characteristics for verification
- Elements for verification for different instruments
- Verification for drug substances and dosage forms
- Acceptance criteria for verification testing
- Handling deviations
- Investigating non-performance: root cause and corrective
actions
- Documenting the verification experiments and results
- Typical costs of method verification
And for easy and instant implementation:
download 10+ documents from special seminar website
- SOPs:
- Verification of compendial methods
- Validation of Chromatographic Methods
- Checklist:
- Verification of Compendial Methods
- Validation of Analytical Methods and Procedures
- Reference Article
- Validation of standard methods
- Validation of HPLC Methods
- Validation of analytical methods: review and procedures
- Warning letters and/or Inspectional observations related to
analytical methods
- FDA presentations on method validation
- How Much Can You Change An Official Method Before It Isn‘t The
Official Method Anymore?
- Analytical Methods Validation, A Regulatory Perspective
- USP Presentation with examples: Verification of Compendial
Procedures
- FDA Guidance
- Analytical procedures and methods validation
- ICH Guidelines for the Industry
- Text on Validation of Analytical Procedures
- Validation of Analytical Procedures: Methodology
- EURACHEM: The Fitness for Purpose of Analytical Methods, 70
pages (link).
Who should attend?
- Laboratory managers and staff
- Analysts
- QA managers and personnel
- Regulatory affairs
- Training departments
- Documentation department
How to order
Pick one of the options in the table that fits your needs.
|
Recorded seminar - Web download 'Site'
offer
- Multiple persons - single site
- Learn at your desk, meet in a seminar or conference room or share the
audio file and reference material at your site.
- Order includes all reference material.
|
US$ 349.-

|
|
Recorded seminar - CD
- Get the CD in your mail
- Order includes all reference material.
|
US$ 349.-

|
|
Special offer for Labcompliance
Usersclub Members
Recorded Seminar- CD or Web download.
- Order includes all reference material.
- for Usersclub information and registration,
click here
|
US$ 249.-

|
About audio seminars

Online audio seminars are presented over the
phone. During the live presentation attendees can:
- Study the printed slide material
- Watch the slides on a computer
- Watch the slides on a video screen in a seminar room
- Ask questions through email and web form
About Dr. Ludwig Huber
Dr. Ludwig Huber is the author of the Labcompliance Newsletter. He has been
conducting over 100 web and audio or video based seminars since ten years. He is
worldwide director for FDA compliance at Agilent Technologies.
|
Dr. Ludwig Huber
is a frequent presenter at IVT conferences and has been
awarded as the 'Presenter of the Year' out of 170 speakers.
This photo is from IVT's conference on Network Qualification
with Ludwig Huber as plenary speaker. |
Dr. Huber has published several books related to validation and
compliance, for example: Validation of Computerized Analytical and
Networked Systems. He was or still is a member of several
committees, e.g., of the GAMP Special interest group (SIG) on
Laboratory Computers, PDA Part 11 task force, IVT task force on
network infrastructure qualification and the European Compliance
Academy. He frequently visits FDA in Rockville, VA, and participates
in panel discussions with FDA professionals. For more information,
click here.